A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure

Endocrine Practice

Volumn 17, Issue 3, 2011, Pages 395-403

  Davidson, Mayer B ^a   Raskin, Philip ^b   Tanenberg, Robert J ^c   Vlajnic, Aleksandra ^d   Hollander, Pricilla ^e  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d SANOFI   (France)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG TREATMENT FAILURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; TREATMENT FAILURE; YOUNG ADULT;

EID: 79959645873     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP10323.OR     Document Type: Article

References (20)

1. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33:S11-S61.
2. Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: The National Health and Nutrition Examination Survey. Diabetes Care. 2006;29:531-537. (Pubitemid 44115349)
3. Hoerger TJ, Segel JE, Gregg EW, Saaddine JB. Is glycemic control improving in U.S. adults? Diabetes Care. 2008;31:81-86.
4. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR; U.K. Prospective Diabetes Study Group. Sulfonylurea inadequacy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25:330-336. (Pubitemid 41079631)
5. Dailey G. A timely transition to insulin: Identifying type 2 diabetes patients failing oral therapy. Formulary. 2005; 40:114-130. (Pubitemid 40627087)
6. Nathan DM, Buse JB, Davidson MB, et al; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.
7. Dailey G. New strategies for basal insulin treatment in type 2 diabetes mellitus. Clin Ther. 2004;26:889-901. (Pubitemid 38943037)
8. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA(1c). Diabetes Care. 2003;26:881-885. (Pubitemid 36929359)
9. Leahy JL. Intensive insulin therapy in type 1 diabetes mellitus. In: Leahy JL, Cefalu WT, eds. Insulin Therapy. New York, NY: Marcel Dekker, Inc, 2002: 87-112.
10. Mooradian AD, Bernbaum M, Albert SG. Narrative review: A rational approach to starting insulin therapy. Ann Intern Med. 2006;145:125-134. (Pubitemid 46780586)
11. Rave K, Klein O, Frick AD, Becker RH. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes. Diabetes Care. 2006;29:1812-1817. (Pubitemid 44156635)
12. Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ. 2006;32(Suppl 1):9S-18S. (Pubitemid 43206838)
13. Korytkowski M. When oral agents fail: Practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(Suppl 3):S18-S24. (Pubitemid 35034478)
14. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005;28: 1245-1249.
15. Fritsche A, Larbig M, Owens D, Häring HU, GINGER study group. Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab. 2010;12:115-123.
16. Lasserson DS, Glasziou P, Perera R, Holman RR, Farmer AJ. Optimal insulin regimens in type 2 diabetes mellitus: Systematic review and meta-analyses. Diabetologia. 2009;52:1990-2000.
17. Raccah D, Bretzel RG, Owens D, Riddle M. When basal insulin therapy in type 2 diabetes mellitus is not enough-what next? Diabetes Metab Res Rev. 2007;23:257-264. (Pubitemid 46851465)
18. Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA; Orals Plus Apidra and LANTUS (OPAL) study group. Introducing a simplified approach to insulin therapy in type 2 diabetes: A comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs. Diabetes Obes Metab. 2008;10:1178-1185.
19. Nicolucci A, Del Prato S, Vespasiani G. Optimizing basal-plus insulin therapy in type 2 diabetes (T2D): Impact on patient (Pt) quality of life (QoL) and treatment satisfaction (TS)-the ELEONOR Study [abstract 550-P]. Presented at: American Diabetes Association Annual Meeting; June 5-9, 2009; New Orleans, LA.
20. Owens DR, Sert-Langeron C, Riddle MC. Adding a single dose of insulin glulisine to basal insulin glargine plus oral antihyperglycemic drug therapy improves glycemic control in type 2 diabetes: A 6-month proof-of-concept study [abstract 458-P]. Presented at: American Diabetes Association Annual Meeting; June 5-9, 2009; New Orleans, LA.